Nu Skin sells Mavely to Later for $250M; expects ~$207M cash, $10M stock after distributions

NU SKIN ENTERPRISES, INC.

Total consideration $230M cash plus $20M in Purchaser common stock; closed January 2, 2025.
Nu Skin expects to retain ~$207M cash and $10M stock after payments to other Mavely equity holders.
Transaction generated ~5x return on Nu Skin's cumulative investment in Mavely since 2021 acquisition.
Proceeds to be used for debt reduction, innovation, and share repurchases under existing program.
Mavely to continue providing technology and social commerce capabilities to Nu Skin's affiliate marketing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.